Table 4.
Rest 1 | Normoxic exercise | Rest 2 | Steady‐state hypoxia | Hypoxic exercise | |
---|---|---|---|---|---|
Control | |||||
pHa | 7.45 ± 0.01 | 7.44 ± 0.01 | 7.44 ± 0.01 | 7.45 ± 0.01 | 7.43 ± 0.01 |
(mmHg) | 31.2 ± 1.5 | 32.0 ± 1.7 | 32.7 ± 1.0 | 32.1 ± 1.1 | 32.0 ± 1 |
[Hb]a (g dL−1) | 14.7 ± 0.4 | 14.7 ± 0.4 | 14.5 ± 0.4 | 14.5 ± 0.4 | 14.4 ± 0.3 |
(%) | 96.0 ± 0.5 | 96.3 ± 0.3 | 96.1 ± 0.3 | 79.6 ± 0.8†‡ | 81.6 ± 0.7†‡ |
(mmHg) | 85.9 ± 3.0 | 88.4 ± 2.8 | 84.5 ± 1.5 | 43.1 ± 0.7†‡ | 46.0 ± 0.6†‡ |
(mL L−1) | 197 ± 5 | 197 ± 5 | 195 ± 5 | 159 ± 5†‡ | 164 ± 5†‡ |
Na+/K+‐ATPase, KIR channel block | |||||
pHa | 7.45 ± 0.01 | 7.44 ± 0.01 | 7.44 ± 0.01 | 7.45 ± 0.01 | 7.44 ± 0.01 |
(mmHg) | 29.7 ± 1.0* | 29.2 ± 1.1* | 31.7 ± 1.1 | 30.0 ± 1.2* | 31.2 ± 1.1 |
[Hb]a (g dL−1) | 14.9 ± 0.4 | 14.4 ± 0.4† | 14.9 ± 0.4* | 14.8 ± 0.4 | 15.0 ± 0.4* |
(%) | 96.4 ± 0.2 | 96.2 ± 0.2 | 96.1 ± 0.2 | 80.5 ± 0.9†‡ | 80.4 ± 0.7†‡ |
(mmHg) | 87.0 ± 2.1 | 86.9 ± 2.1 | 84.3 ± 1.7 | 43.9 ± 0.8†‡ | 44.4 ± 0.9†‡ |
(mL L−1) | 201 ± 6 | 194 ± 6 | 200 ± 6 | 165 ± 6†‡ | 168 ± 5†‡ |
* P < 0.05 vs. control; † P < 0.05 vs. rest (within trial); ‡ P < 0.05 vs. normoxic exercise; all comparisons within protocol.